We are live on ! Find out more
ASP

Adams Street Partners Portfolio holdings

AUM $260M
1-Year Est. Return 30.38%
This Fund
S&P 500
This Quarter Est. Return
+32.65%
1 Year Est. Return
+30.38%
3 Year Est. Return
+351.96%
5 Year Est. Return
+202.05%
10 Year Est. Return
+1,159.77%
AUM
$113M
AUM Growth
+$142K
Cap. Flow
-$17.9M
Cap. Flow %
-15.88%
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$1.42M
2
TEM
Tempus AI
TEM
+$500K

Top Sells

Rank Stock Value
1
MLYS icon
Mineralys Therapeutics
MLYS
+$13.9M
2
PAY icon
Paymentus
PAY
+$5.95M

Sector Composition

Rank Sector Weight
1 Technology 74.28%
2 Healthcare 19.77%
3 Industrials 4.47%
4 Communication Services 1.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMNI icon
1
Rimini Street
RMNI
$453M
$82M 72.6%
23,565,433
PVLA
2
Palvella Therapeutics
PVLA
$2.05B
$11.5M 10.15%
409,666
CRVS icon
3
Corvus Pharmaceuticals
CRVS
$1.12B
$10.4M 9.22%
3,275,616
VCSA
4
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$5.05M 4.47%
938,221
PAY icon
5
Paymentus
PAY
$4.29B
$1.9M 1.69%
72,968
-201,071
-73% -$5.95M
BZ icon
6
Kanzhun
BZ
$7.07B
$1.67M 1.48%
+87,157
New +$1.42M
TEM
7
Tempus AI
TEM
$7.72B
$447K 0.4%
+9,266
New +$500K
MLYS icon
8
Mineralys Therapeutics
MLYS
$2.38B
-1,129,807
Closed -$13.9M

Similar funds

Adams Street Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Adams Street Partners held 8 positions worth $113M, up 0.13% from $113M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Adams Street Partners withdrew a net $17.9M in Q1 2025, closing 1 position and reducing 1 holding. Its most notable exit was Mineralys Therapeutics, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 74% of assets, up from 64% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Adams Street Partners opened a new position in Kanzhun worth $1.67M.

  • Adams Street Partners's largest Q1 2025 buy was Kanzhun: 87,157 shares worth $1.67M.
  • Adams Street Partners's biggest Q1 2025 reduction was Paymentus, cutting an estimated $5.95M.
  • Adams Street Partners fully exited Mineralys Therapeutics in Q1 2025, selling an estimated $13.9M.
  • Adams Street Partners's ten largest holdings make up 100% of its $113M portfolio in Q1 2025.
  • Adams Street Partners opened 2 new positions and closed 1 in Q1 2025.
  • Adams Street Partners's portfolio value rose 0.13% quarter-over-quarter to $113M.

Based on Adams Street Partners's 13F filing for Q1 2025, filed 14 May 2025.